Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-09
2009-10-06
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S300000, C546S118000, C546S113000
Reexamination Certificate
active
07598266
ABSTRACT:
The present invention is directed to compounds represented by the following structural formula, Formula I:wherein:(a) X is selected from the group consisting of a single bond, O, S, S(O)2and N;(b) U is an aliphatic linker;(c) Y is selected from the group consisting of C, O, S, NH and a single bond;(d) E is C(R3)(R4)A or A and wherein(i) A is selected from the group consisting of carboxyl, tetrazole, C1-C6alkylnitrile, carboxamide, sulfonamide and acylsulfonamide;(e) B is selected from the group consisting of S, O, C, and N;(f) Z is selected from the group consisting of N and C; with the proviso that when B is C then Z is N.
REFERENCES:
patent: 5859051 (1999-01-01), Adams
patent: 7384965 (2008-06-01), Conner et al.
patent: 1 167 357 (2002-02-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 01/00603 (2001-01-01), None
patent: WO 03/066574 (2003-08-01), None
Byrn et al. Solid-State Chemistry of Drugs, 2d, Chapter 11 Hydrates and Solvates, 233-247, 233.
Rami, H.K., et al, “Synthetic ligands for PPAR gamma—review of patent literature 1994-1999”, Expert Opinion Ther. Patents, 2000, 10(5):623-634.
Conner Scott Eugene
Mantlo Nathan Bryan
Zhu Guoxin
Anderson Rebecca L
Eli Lilly and Company
Nolan Jason
Vorndran-Jones MaCharri
LandOfFree
Fused heterocyclic derivatives as PPAR modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused heterocyclic derivatives as PPAR modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused heterocyclic derivatives as PPAR modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4059978